You are here: Industry Insights > antibody

News List

Vir selects Samsung Biologics to produce Covid-19 antibodies pharmaceutical-technology
April 14, 2020
Immunology company Vir Biotechnology has selected South Korea-based Samsung Biologics for large-scale production of antibodies to potentially treat Covid-19.
‘Directing’ evolution to identify potential drugs earlier in discovery expresspharma
April 14, 2020
Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease.
AstraZeneca begins efforts to identify antibodies against Covid-19 pharmaceutical-technology
April 10, 2020
AstraZeneca has begun research efforts focused on the identification and development of antibody therapies against Covid-19 coronavirus infection.
GigaGen works on recombinant polyclonal antibody against Covid-19 pharmaceutical-technology
April 01, 2020
Biotechnology company GigaGen is working on a recombinant polyclonal antibody, recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.
BioDuro to Develop COVID-19 Nanobody Therapeutic contractpharma
March 30, 2020
Specialized COVID-19 team and technology assembled to accelerate discovery of new biologic.
Samsung Biologics, APRINOIA Enter mAb Pact contractpharma
March 18, 2020
Samsung will provide cell line development, process development, cGMP manufacturing to IND filing support, for Alzheimer's antibody candidate.
A world premiere from Erasmus MC and Utrecht University: they found an antibody against COVID-19 worldpharmanews
March 16, 2020
Since Thursday evening, the article by a team of ten scientists has been online on BioRxiv - a website where biologists can publish their research before it will be assessed ...
AbCellera, Lilly Partner to Develop Antibodies Against COVID-19 contractpharma
March 16, 2020
Will leverage AbCellera's rapid pandemic response platform and Lilly's global development, manufacturing and distribution capabilities.
Biogen, Vir Enter COVID-19 Antibody Alliance contractpharma
March 16, 2020
Biogen will provide cell line development, process development and clinical manufacturing for Vir's monoclonal antibodies.
Mutations in plasma cells play a key role in light-chain amyloidosis expresspharma
March 12, 2020
The team of scientists succeeded in identifying eleven mutations caused by the disease in the antibodies of a patient with advanced AL amyloidosis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page